Akcea Therapeutics And AKCEA-ANGPTL3-LRx: The Story [Seeking Alpha]
AKCEA THERAPEUTICS (AKCA)
Last akcea therapeutics earnings: 2/25 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.akceatx.com/media-investors/press-releases
Company Research
Source: Seeking Alpha
Akcea Therapeutics And AKCEA-ANGPTL3-LRx: The Story Summary Liver Therapy Forum weekly digest provides an overview on what’s happening in liver diseases in 2019. This week’s spotlight is Akcea Therapeutics. Akcea is developing antisense-based therapeutics for the treatment of rare diseases and cardiovascular events associated with dyslipidemia. Its thesis is that RNA silencing of ANGPTL3 is a viable therapeutic target for treating dyslipidemia to prevent potential cardiovascular events in high risk patients. Significantly, clinical studies in ANGPTL3 deficient individuals have revealed an association with improved dyslipidemia. Market Assessment Akcea Therapeutics ( AKCA IONS diverse pipeline Its two commercialized products, Tegsedi and Waylivra (formerly volanesorsen), are for the treatment of hereditary transthyretin-mediated amyloidosis familial chylomicronemia syndrome Fig. 1: Drug Pipeline For Cardiometabolic Lipid Disorders Angiopoietin-like proteins, ANGPTL, are a family of pro
Show less
Read more
Impact Snapshot
Event Time:
AKCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
AKCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
AKCA alerts
High impacting AKCEA THERAPEUTICS news events
Weekly update
A roundup of the hottest topics